Hutchmed
Clinical trials sponsored by Hutchmed, explained in plain language.
-
New hope for rare blood disorder: drug trial targets anemia that Won't quit
Disease control OngoingThis study tests an experimental drug called HMPL-523 for people with warm antibody autoimmune hemolytic anemia, a condition where the immune system destroys red blood cells. The goal is to see if the drug can safely raise hemoglobin levels and control the disease. About 111 adul…
Phase: PHASE2, PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
ITP drug study halted before it began
Disease control TerminatedThis study was designed to test an experimental drug called HMPL-523 in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The goal was to see if the drug is safe and can raise platelet counts. However, th…
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 18, 2026 12:10 UTC